CTOs on the Move

Tegra Medical

www.tegramedical.com

 
Tegra Medical is focused exclusively on the medical device industry, providing precision machining and contract manufacturing services.   Tegra uses a wide range of manufacturing technologies to produce complex components and finished devices used in cutting-edge procedures for leading surgical, interventional and orthopaedic companies.   Tegra has 200,000 sq. ft. of modern manufacturing space in four locations and is ISO 13485:2003, ISO 9001:2008, and FDA registered and QSR compliant.   The company combines a broad spectrum of capabilities with a can-do culture to deliver exceptional solutions, speed and service.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

DURECT Corporation

DURECT Corporation is a Cupertino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tyber Medical

Tyber Medical, LLC is an orthopedic device manufacturer providing rapid access to portfolio enhancing, regulatory approved, orthopedic implants within the spine and extremity/trauma markets. While focusing on rapid product commercialization, the company distributes products via private labeling; releasing 14 spine and 25 extremity/trauma systems since its founding in 2012. Tyber Medical utilizes the differentiated, bioengineered technology such as TyPEEK® osteoconductive coatings and BioTy™, a new antimicrobial nano-textured surface modification to enhance the company`s growing portfolio.

Canadian Agency for Drugs and Technologies

Canadian Agency for Drugs and Technologies is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.

A Plus Intl

A Plus Intl is a Chino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.